Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Are Buybacks Really Shortchanging Investment
Fried, Jesse M.; Wang, Charles C.Y.Artículo HBS-R1802F-ESome experts argue that corporate leaders are starving their firms of investment capital by making excessive payouts to shareholders, thereby undermining innovation, employment opportunity, and economic growth. As evidence, they point to S&P 500 firms' using 96% of their net income for repurchases and dividends. A closer look at the data shows that the amounts going to shareholders at the expense of internal investment are less than claimed. The ...Desde 8,20 €
-
New Constructs: Disrupting Fundamental Analysis with Robo-Analysts
Wang, Charles C.Y.; Thomas, KyleCaso HBS-118068-EContabilidad y controlUsing machine-learning technology, New Constructs creates cleaned up financial statement data that removes accounting distortions. This powerful data aims to provide unparalleled insights into companies' true economic picture. Could they convince market pDesde 8,20 €
-
George's T-Shirts
Frey, Sherwood C. Jr.; Pfeifer, Phillip E.Caso DARDEN-QA-0346-EAnálisis de decisionesGeorge Lasiter sells special-events T-shirts and must decide how many to order for an upcoming concert. He has high, medium, and low estimates of both concert attendance and the percentage of attendees who will want a shirt. In addition, he has assessed the relative likelihoods of each estimate. The case can be used to introduce or reinforce the fundamental issues surrounding decision making under uncertainty.Desde 8,20 €
-
Merck & Company: Product KL-798
Frey, Sherwood C. Jr.; Bodily, Samuel E.Caso DARDEN-QA-0582-EAnálisis de decisionesMerck has been approached by a small biotech research firm with the proposal that Merck buy the rights to a new drug that promises to treat obesity and lower cholesterol. The drug is in the middle of phase I of the FDA approval process. Pat Harlow, the chief licensing officer, has been leading Merck's investigation team. A meeting is scheduled for tomorrow at which Merck's response to the offer will be drafted.Desde 8,20 €
-
Merck & Company: Product KL-798 (Spanish version)
Frey, Sherwood C. Jr.; Bodily, Samuel E.Caso DARDEN-QA-0910Análisis de decisionesEsta es una traducción al español de la versión del 14 de junio de 2016 del caso UVA-QA-0582. Merck ha sido contactado por una pequeña empresa de investigación en biotecnología con una propuesta para que Merck compre los derechos de un nuevo medicamento que promete tratar la obesidad y reducir el colesterol. El medicamento se encuentra en la mitad de la fase I del proceso de aprobación de la FDA. Pat Harlow, el director de licencias, ha estado al...Desde 8,20 €
-
Madison House: Riley Carter
Frey, Sherwood C. Jr.; Bass, Lucien; Grant, MaxCaso DARDEN-QA-0803-EAnálisis de decisionesThis two-part negotiation exercise is used in Negotiations electives at both the Darden School of Business and the McIntire School of Commerce. Together the cases provide the background for a scorable, bilateral, multi-issue negotiation in which there are congruent, distributive, and integrative issues. People and Congregations Engaged in Ministry (PACEM) was a nonprofit organization committed to helping homeless adults in the Charlottesville, Vi...Desde 8,20 €
-
PACEM: Kennedy Brooks
Frey, Sherwood C. Jr.; Bass, Lucien; Grant, MaxCaso DARDEN-QA-0802-EAnálisis de decisionesThis two-part negotiation exercise is used in Negotiations electives at both the Darden School of Business and the McIntire School of Commerce. Together, the cases provide the background for a scorable, bilateral, multi-issue negotiation in which there are congruent, distributive, and integrative issues. People and Congregations Engaged in Ministry (PACEM) was a nonprofit organization committed to helping homeless adults in the Charlottesville, V...Desde 8,20 €
-
Turkcell, Teaching Note
Oberholzer-Gee, Felix; Wang, Charles C.Y.; Cekin, EselNota del Instructor HBS-116040-EDirección estratégicaTeaching Note for case 115009.Desde 0,00 €
-
Walgreen and Alliance Boots
Gow, Ian D.; Wang, Charles C.Y.; Thomas, KyleCaso HBS-115046-EContabilidad y controlDesde 8,20 €
-
Turkcell
Oberholzer-Gee, Felix; Wang, Charles C.Y.; Cekin, EselCaso HBS-715009-EDirección estratégicaThis case centers around the shareholder dispute between three major shareholders of Turkcell, and how its management vied against increasing regulatory intervention and market competition in the absence of a fully-functioning board. The battle for control of the Turkish telecom giant led to several years in which the company could not hold annual shareholder meetings, renew its board of directors, or pay dividends, and lacked a board-approved op...Desde 8,20 €